Your browser doesn't support javascript.
loading
Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.
Abbasi, Batol; Shamsasenjan, Karim; Ahmadi, Majid; Beheshti, Seyedeh Ameneh; Saleh, Mahshid.
Afiliación
  • Abbasi B; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Shamsasenjan K; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ahmadi M; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. shamsk@tbzmed.ac.ir.
  • Beheshti SA; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran. shamsk@tbzmed.ac.ir.
  • Saleh M; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Stem Cell Res Ther ; 13(1): 97, 2022 03 07.
Article en En | MEDLINE | ID: mdl-35255980
ABSTRACT
Natural killer cells (NK cells) are innate immune cells that are activated to fight tumor cells and virus-infected cells. NK cells also play an important role in the graft versus leukemia response. However, they can over-develop inflammatory reactions by secreting inflammatory cytokines and increasing Th1 differentiation, eventually leading to tissue damage. Today, researchers have attributed some autoimmune diseases and GVHD to NK cells. On the other hand, it has been shown that mesenchymal stem cells (MSCs) can modulate the activity of NK cells, while some researchers have shown that NK cells can cause MSCs to lysis. Therefore, we considered it is necessary to investigate the effect of these two cells and their signaling pathway in contact with each other, also their clinical applications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunomodulación / Células Madre Mesenquimatosas Idioma: En Revista: Stem Cell Res Ther Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunomodulación / Células Madre Mesenquimatosas Idioma: En Revista: Stem Cell Res Ther Año: 2022 Tipo del documento: Article País de afiliación: Irán